Skip to main content

Table 2 In vivo (N = 10) PC-MRI measures of total flow and peak velocity.

From: Convex gradient optimization for increased spatiotemporal resolution and improved accuracy in phase contrast MRI

 

FCFE

CVX-SR

CVX-TR

Total Flow (mL)

aAo

89.0 ± 18.2

95.9 ± 19.4†

93.5 ± 17.9†

PA

92.6 ± 18.5

100.1 ± 20.1†

97.2 ± 18.0†,‡

RPA

48.1 ± 9.5

52.5 ± 9.9†

50.9 ± 9.5†,‡

LPA

44.3 ± 8.7

47.7 ± 10.2†

46.4 ± 9.0†

Peak Velocity (cm/s)

aAo

117.2 ± 17.2

121.6 ± 15.3†

127.3 ± 15.8†,‡

PA

87.0 ± 11.8

90.0 ± 13.5†

95.4 ± 15.4†,‡

RPA

93.8 ± 15.9

97.1 ± 16.8†

104.7 ± 21.7†,‡

LPA

95.3 ± 18.0

99.7 ± 19.8†

107.2 ± 19.9†,‡

  1. Data are expressed as mean ± standard deviation † P < 0.05 shows a statistical significant difference compared to FCFE. ‡ P < 0.05 shows a statistical significant difference compared to CVX-SR.